Koulshan Jameel, Gul-e-rana Abdul Mannan, Durr-e-shahwar Hayat, Rabiya Niaz, Anum Sultan
{"title":"子宫经皮瘘的医学治疗:一例报告。","authors":"Koulshan Jameel, Gul-e-rana Abdul Mannan, Durr-e-shahwar Hayat, Rabiya Niaz, Anum Sultan","doi":"10.29052/ijehsr.v11.i2.2023.104-109","DOIUrl":null,"url":null,"abstract":"Background: The uterocutaneous fistula is an abnormal connection or passageway between the uterus and the skin. The most common causes include infections, trauma, or surgery, a severe medical condition requiring prompt medical attention and treatment. \nCase Presentation: Here, we describe the case of a 36-year-old female who developed a uterocutaneous fistula after cesarean delivery. Her post-cesarean recovery was complicated by wound infection, and after healing the wound, she presented with cyclical bloody discharge from a pinpoint opening in the healed wound scar. \nManagement: On ultrasound and MRI, she was diagnosed as having a uterocutaneous fistula. She opted for non-surgical management and underwent successful medical management with GnRH agonists. She remained symptom-free after the resumption of her menstrual cycle. \nConclusion: In younger populations hoping to avoid surgery, pharmacological care with GnRH agonist therapy can be a reasonable alternative to surgical resection of the fistulous tract. Healthcare professionals should have a high index of suspicion to diagnose this condition.","PeriodicalId":34196,"journal":{"name":"International Journal of Endorsing Health Science Research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Uterocutaneous fistula managed medically: A case report.\",\"authors\":\"Koulshan Jameel, Gul-e-rana Abdul Mannan, Durr-e-shahwar Hayat, Rabiya Niaz, Anum Sultan\",\"doi\":\"10.29052/ijehsr.v11.i2.2023.104-109\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: The uterocutaneous fistula is an abnormal connection or passageway between the uterus and the skin. The most common causes include infections, trauma, or surgery, a severe medical condition requiring prompt medical attention and treatment. \\nCase Presentation: Here, we describe the case of a 36-year-old female who developed a uterocutaneous fistula after cesarean delivery. Her post-cesarean recovery was complicated by wound infection, and after healing the wound, she presented with cyclical bloody discharge from a pinpoint opening in the healed wound scar. \\nManagement: On ultrasound and MRI, she was diagnosed as having a uterocutaneous fistula. She opted for non-surgical management and underwent successful medical management with GnRH agonists. She remained symptom-free after the resumption of her menstrual cycle. \\nConclusion: In younger populations hoping to avoid surgery, pharmacological care with GnRH agonist therapy can be a reasonable alternative to surgical resection of the fistulous tract. Healthcare professionals should have a high index of suspicion to diagnose this condition.\",\"PeriodicalId\":34196,\"journal\":{\"name\":\"International Journal of Endorsing Health Science Research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Endorsing Health Science Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29052/ijehsr.v11.i2.2023.104-109\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Endorsing Health Science Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29052/ijehsr.v11.i2.2023.104-109","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Uterocutaneous fistula managed medically: A case report.
Background: The uterocutaneous fistula is an abnormal connection or passageway between the uterus and the skin. The most common causes include infections, trauma, or surgery, a severe medical condition requiring prompt medical attention and treatment.
Case Presentation: Here, we describe the case of a 36-year-old female who developed a uterocutaneous fistula after cesarean delivery. Her post-cesarean recovery was complicated by wound infection, and after healing the wound, she presented with cyclical bloody discharge from a pinpoint opening in the healed wound scar.
Management: On ultrasound and MRI, she was diagnosed as having a uterocutaneous fistula. She opted for non-surgical management and underwent successful medical management with GnRH agonists. She remained symptom-free after the resumption of her menstrual cycle.
Conclusion: In younger populations hoping to avoid surgery, pharmacological care with GnRH agonist therapy can be a reasonable alternative to surgical resection of the fistulous tract. Healthcare professionals should have a high index of suspicion to diagnose this condition.